CIDRAP: Recombinant Pertussis Vaccine May Protect Teens For At Least 5 Years Researchers report that immunity against pertussis (whooping cough) was sustained 5 years after receipt of a ...

The split intein-mediated protein ligation (SIMPL) system for detecting protein-protein interactions has been enhanced by ...

PhaseV, a pioneer in software and machine learning (ML) for advanced clinical trial optimization, announced today it will present at the AHLI Machine Learning for Health (ML4H) 2024 Symposium, taking ...

BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...

The editor’s pick for this issue is a review article discussing the promise of hyperpolarised xenon MRI, a non-invasive ...

Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.

Almac Clinical Technologies is a global provider of Interactive Response Technology (IRT) and expert consultancy for the biopharmaceutical industry, empowering trial sponsors to pro-actively manage ...

The clinical trial is divided into two phases. During the first phase, up to 60 subjects, ages 7 to 17 with ADHD will be enrolled at four sites in Denmark to receive active or sham eTNS treatment for ...

Josh Jennings, an analyst from TD Cowen, maintained the Buy rating on TransMedics Group (TMDX – Research Report). The associated price target ...

The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.

Traumatic brain injury (TBI) is a leading cause of death and disability among young people in the United States and is the most devastating survivable injury in modern warfare, according to the ...